SERES THERAPEUTICS revenue breakdown overview

SERES THERAPEUTICS revenue for the last year amounted to 106.36 M CHF, the most of which — 106.36 M CHF — came from its highest performing source at the moment, Microbiome Therapeutics, the year earlier bringing 6.59 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought SERES THERAPEUTICS 106.36 M CHF, and the year before that — 6.59 M CHF.